Harmony Biosciences Holdings (HRMY) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
HRMY is expected to report earnings to fall 15.15% to 67 cents per share on February 19
Q4'24
Est.
$0.67
Q3'24
Beat
by $0.12
Q2'24
Beat
by $1.04
Q1'24
Beat
by $0.25
Q4'23
Beat
by $0.01
The last earnings report on October 29 showed earnings per share of 79 cents, beating the estimate of 67 cents. With 598.33K shares outstanding, the current market capitalization sits at 1.89B.
a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders